Human percutaneous laser angioplasty. Patient selection criteria and early results

Percutaneous transluminal laser angioplasty is a new method for treating atherosclerotic disease previously not amenable to routine percutaneous transluminal angioplasty techniques. Our results compared favorably with other clinical trials. Patient selection criteria include lesions in the superficial femoral or popliteal system not capable of being treated with routine percutaneous transluminal angioplasty. We think that these lesions include high-grade stenoses or short segmental occlusions. Heavily calcified vessels and long segment occlusions measuring greater than 12 cm in length are probably not amenable to percutaneous transluminal laser angioplasty. The long-term results of this form of therapy for peripheral vascular disease remain unknown.